9 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... pharmacotherapy #table ... #comparison #management
Algorithm for the Treatment of Membranous Lupus Nephritis
Sub-nephrotic-range proteinuria (<3.5g/d, normal serum albumin) and Preserved kidney
Algorithm for the ... immunosuppression to treat class ... therapy to treat class ... #Treatment #management ... #nephrology
Treatment Algorithm for Active Proliferative Lupus Nephritis (Class III/IV or Mixed Class III/IV + V)
Induction Therapy
Treatment Algorithm ... Lupus Nephritis (Class ... III/IV or Mixed Class ... Lupus #Nephritis #management ... #nephrology
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Framework and Management ... Direct myoglobin ... per day until stable ... Differential #Diagnosis #Management ... #nephrology
Summary of characteristic abnormalities of selected glomerular diseases
Light Microscopy (LM) - Immunofluorescence Microscopy (IM) - Electron
Lupus ISN/RPS class ... glomerular #diseases #nephrology ... #pathology #comparison ... #table #diagnosis
Aortoenteric Fistula - Diagnosis and Management Summary
Epidemiology:
• Uncommon but life-threatening
• Most common site of bowel connection
Diagnosis and Management ... /Symptoms: • Classic ... intervention, no matter ... should be taken directly ... Management: SURGERY
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Heart Association class ... Excretion #Diuresis #Nephrology ... #Medications #Table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
metabolic equivalent able ... ASA class If ... event, follow ACC algorithm ... Stable patients ... medical and surgical management
Indications for Implantable Cardioverter-Defibrillator (ICD) in Patients with Ischemic Heart Disease (IHD) to Prevent Sudden Cardiac
LVEF < 35%, NYHA class ... management and ... LVEF < 30%, NYHA class ... management and ... unstable VT • Stable